Long non-coding RNAs: a rising biotarget in colorectal cancer

Oncotarget. 2017 Mar 28;8(13):22187-22202. doi: 10.18632/oncotarget.14728.

Abstract

Colorectal cancer (CRC) is a common gastrointestinal cancer, with a high incidence and high mortality. Long non-coding RNAs (lncRNAs) are involved in the development, invasion and metastasis, early diagnosis, prognosis, the chemoresistance and radioresistance of CRC through interference with mRNA activity, directly combining with proteins to regulate their activity or alter their localization, influencing downstream gene expression by inhibiting RNA polymerase and regulating gene expression as competing endogenous RNAs. Recent progress in next generation sequencing and transcriptome analysis has revealed that tissue and cancer-type specific lncRNAs could be useful prognostic markers. Here, the CRC-associated lncRNAs from recent studies until October 2016 are reviewed and multiple studies that have confirmed CRC-associated lncRNAs are summarized. This review may be helpful in understanding the overall relationships between the lncRNAs involved in CRC.

Keywords: colorectal cancer; epithelial-mesenchymal transition; invasion; long non-coding RNAs.

Publication types

  • Review

MeSH terms

  • Animals
  • Colorectal Neoplasms / genetics*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • RNA, Long Noncoding / genetics*

Substances

  • RNA, Long Noncoding